Skip to Main Content

Paper Details

EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway.
Proc Natl Acad Sci U S A
3
2022
EBF1, Early B cell factor 1, HIF1, TNBC, breast cancer, p300, transcriptional regulatory network, triple-negative breast cancer, tumor
Author NameAffiliation
Deng PanDepartment of Pharmaceutical Sciences, College of Medicine, The University of Kentucky
Rudolf GrosschedlMax Planck Institute of Immunobiology and Epigenetics
  • 1 - 2

Datasets

Release 1.2